I'm trying best to bite my tongue... was told in Feb "we are in a strong cash position". With the divestment of the argentine asset. We wait and see but the last CR wasn't good.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress